Wako
Wako
Specialty Chemicals Home Custom Synthesis Polymer related fields Pharmaceutical & cosmetic fields Electronics materials Intermediates

Pharmaceutical & cosmetic fields

Biodegradable Polymers

Specialty Chemicals Home > biodegradable Polymers(PLA. PLGA)

biodegradable Polymers(PLA. PLGA)

PLA(poly lactic acid) and PLGA ( copoly lactic acid/glycolic acid) are superior in biocompatibility and biodegradability, and are useful materials as base material for sustained-release formulation. We have been providing PLA and PLGA not only as laboratory reagents but also produced under GMP controlled condition

  • No contamination from catalysts such as heavy metals because of uncatalyzed reaction.
  • We are able to provide an injectable formulation grade produced on industrial scale as required by the customers.
  • Our PLA and PLGA of general grade are for laboratory use.
product code product name composition rate weight-average molecular weight inherent viscosity
(dl/g)
DL-lactic acid glycollic acid
825-11806
PLA-0005
100 0 5,000
0.085-0.099
822-11816
PLA-0010
100 0 10,000
0.118-0.137
829-11826
PLA-0015
100 0 15,000
0.147-0.177
826-11836
PLA-0020
100 0 20,000
0.177-0.216
829-11946
PLGA-7505
75 25 5,000
0.082-0.098
826-11956
PLGA-7510
75 25 10,000
0.119-0.140
823-11966
PLGA-7515
75 25 15,000
0.152-0.185
820-11976
PLGA-7520
75 25 20,000
0.186-0.230
821-11906
PLGA-5005
50 50 5,000
0.088-0.102
828-11916
PLGA-5010
50 50 10,000
0.122-0.143
825-11926
PLGA-5015
50 50 15,000
0.154-0.186
822-11936
PLGA-5020
50 50 20,000
0.187-0.229

Product weight is only 25 g. Prohibit any purpose without research use or test because these products are not control under GMP or GLP.
Please contact us separately in case where the purpose is application for medical products.

degradability data

Degradability of PLGA within an organism changes according to monomer composition. When monomer composition rate is 50/50, the degradability kinetics is the fastest and the degradability kinetics is slowed to such an extent that monomer composition rate comes free from 50/50.(Fig. 1.)

As shown on Fig. 2, releasing capacity of microencapsulated TRH (thyrotropin-releasing hormone) tends to be bigger in the order corresponding to 50/50>75/25>100/0 in rate of lactic acid and glycol. The releasing capacity is associated with degradability of PLGA, as it has been said earlier.

Fig. 3 shows that release rate from microspheres is slowed to such an extent that PLGA Mw. is higher.

When drugs using PLGA are designed, it is important to chooce most suitable composition of PLGA and its Mw. When PLGA is applied to controled release formulation, it is necessary to screen various PLGAs in vitro or vivo because the change of drug release depends on drug itself.
Fig. 1. Half life of various of lactic acid and glycolic acid as copolymers implanted in rat tissue.
Fig. 2. Release profiles of TRH from PLGA microspheres with different copolymer ratios of PLGA.
Fig. 3. Effect of molecular weight of PLGA75/25 on release profiles of TRH microspheres.

References

  • R.Miller, J. M. Brady, and D. Cutright, J. Biome. Mater. Res., 11, 711 (1977).
  • T. Heya, H. Okada, Y. Ogawa, and H. Toguchi, Int. J. Pharm., 72, 199-205 (1991)

Click here for further information of interested requests.

Copyright © 1997-2006 Wako Pure Chemical Industries, Ltd. All Rights Reserved.